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1. Introduction
Vascular access for haemodialysis (HD) and other forms of renal replacement therapy where
access to blood is required (such as haemofiltration) is a broad area that encompasses a vari‐
ety of specialties including nephrology, intensive care, interventional radiology and surgery.
Within the acute setting, vascular access via catheter placement can be performed in an
emergency. However, longer-term access in the form of an arteriovenous fistula (AVF) or
graft requires considerable pre-procedural planning and often involves multidisciplinary in‐
put throughout the patient’s “dialysis lifetime”. In this chapter, we aim to discuss the com‐
mon types of access and provide a holistic approach from a UK perspective, whilst also
focussing on some practical aspects that have been noted from our personal experience and
evidence-base.
1.1. Identification of patients who require vascular access
In the setting of acute kidney injury (AKI), a vascular catheter is the commonest access route
for HD. There has to be a clear indication for insertion and this may include satisfying stage
3 of the Acute Kidney Injury Network classification, life-threatening hyperkaemia refractory
to medical therapy, acidosis, uraemia and fluid overload resistant to diuretic therapy [1].
Nonetheless, there may be other specific indications considered on a “case-by-case” basis.
Such instances include anticipation of non-recovery from AKI or those with chronic kidney
disease (CKD) who receive debulking chemotherapy for haematological malignancies and
may not cope with rapid rises in urate and potassium from cell lysis [2].
In CKD, it  is  generally recommended that plans to establish any form of dialysis access
should be discussed with the patient between stages 4 to 5 (estimated glomerular filtra‐
tion rate of 30 ml.min.1.73m2-1 or less) and an informed decision documented [3]. In HD,
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this often involves surgery for an autogenous AVF or graft. Vascular catheters are not rec‐
ommended as a first-line approach given their complications. Timely preparation will en‐
sure  the  smoothest  transition towards  renal  replacement  therapy.  Patients  who referred
late for consideration have poorer outcomes compared to those who have been establish‐
ed  with  nephrology  services  for  longer:  they  are  consistently  shown  to  have  increased
mortality,  reduced treatment  choices,  access  to  transplantation,  increased morbidity  and
hospitalisation [4].
One fundamental difference between vascular access types is blood flow and this will deter‐
mine dialysis adequacy (defined as a Kt/V of ≥1.2) [5]. Sometimes, flows are not as optimal
in catheters compared to AVFs or grafts. Regardless, the need for vascular catheters in pa‐
tients with end-stage renal disease is becoming increasingly commonplace in 4/5 patients
who suddenly deteriorate, when AVF or graft is not possible or maturation has failed [6].
Their convenience of insertion and immediate painless use makes them popular with pa‐
tients. Temporary vascular catheters (VC) are generally used for no more than two weeks
(shorter duration for femoral vein catheters), whereas tunnelled cuffed vascular catheters
(TCVC) are indicated for short to long-term venous access. If maintained correctly, such de‐
vices can last for a few years. Although traditionally inserted by an interventional radiolog‐
ist, in many UK centres a nephrologist will now perform the majority of procedures as a day
case. A more recent development within the UK has been the creation of specialist nurse-led
services dedicated to this area [7].
Establishing vascular access will remain the key rate-limiting component for HD. The vascu‐
lar access nurse plays a crucial role in prioritising patients and contributes to a multidiscipli‐
nary approach involving specialist nurses, surgeons, radiologists and nephrologists.
Deciding on when to start dialysis once access is created in CKD is an area of intense debate
but has to be determined on an individual basis. Factors may include rapidity of estimated
glomerular filtration rate (eGFR) decline, symptoms of uraemia, failure to thrive or poor
quality of life. However, the recent Initiating Dialysis Early and Late (IDEAL) trial defini‐
tively demonstrated that elective earlier initiation of dialysis (based on eGFR 10-14 ml.min.
1.73m2-1 vs. 5-7 ml.min.1.73m2-1) was not associated with improved clinical outcomes or
quality of life [8].
2. Types of vascular access
2.1. Arteriovenous fistulae and grafts
2.1.1. Requirements
Preferably, patients should receive counselling on the requirements of HD before referring
for any access procedure. It is useful for them to visit a dialysis unit to experience how treat‐
ment is administered and gain familiarity with environment. This may help to adjust pa‐
tients to a potentially lifelong routine.
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A vascular surgeon at our centre performs AVF and graft surgery. In the UK, both renal
transplant and vascular surgeons provide this service based upon local arrangements. On
considering referral for access surgery, the renal physicians and vascular access nurse assess
both the patient and the upper limb vessels for ease of AVF formation. This is an invaluable
adjunct to the process, as priming both the patient and surgeon regarding potential difficul‐
ties provides for a more effective service.
Once referred, a vascular assessment of the patient is performed with particular focus on
both upper limbs. Clearly, the successful creation of AVF or graft is dependent upon opti‐
mising its location, arterial inflow and venous outflow. In particular, the veins in both upper
limbs should be examined for size, location, and patency whilst simultaneously checking for
the character of radial, ulna and brachial pulses and vessels. The non-dominant limb is usu‐
ally used for access surgery. Where there is a suspicion of arterial disease, we perform upper
limb brachial and radial systolic blood pressure and qualitative Doppler waveform analysis
at the same clinic visit.
Although clinical assessment of the patient is key to the formation of an AVF, ultrasound
duplex scanning can be valuable to assess vessels and quantify flow rates. Surgeons may use
duplex scanning routinely or selectively prior to surgery. Patients with diabetes frequently
represent a greater challenge due to a higher incidence of arterial calcification particularly
more distally at the forearm and wrist: studies demonstrate they are more likely to need a
proximal AVF with their inherent risk of the steal syndrome (see below) [9].
We have seen an increasing trend in more elderly and frail patients being referred for access
surgery. The increased incidence of co-morbidities including cardiac disease, loss of tissue
quality and atherosclerosis in the elderly means that they represent a greater challenge both
in terms of creating a fistula and avoiding associated complications [10]. If a reduction of in‐
flow is identified in the limb being considered for surgery, then magnetic resonance arte‐
riography (MRA) is requested to detail arterial disease. MR or venograms can be performed
if there is suspicion of venous disease particularly in patients with a history of multiple cen‐
tral vascular catheter use: subclavian catheters being well-recognised to predispose to cen‐
tral vein stenosis [11]. Patients with central vein stenoses and occlusions present a
significant obstacle, but can be managed by interventions such as venoplasty and stenting,
and carefully selecting the site of venous anastomosis.
Informed consent for access surgery should include detail not only on the reasons for sur‐
gery and explanation of the procedure, but also information on the immediate and longer
term complications that may occur. This should be based on the individual surgeons prac‐
tice and observations [12]. The type and frequency of complications that we include in dis‐
cussion, comprises of failure to achieve a usable fistula, haemorrhage, ischaemia, damage to
surrounding structures including nerves and wound complications. Over 90% of our access
surgery is performed as a day-case under local anaesthesia.
Given the burden of cardiovascular disease, it is common to find patients on antiplatelet and
anticoagulant medication. Aspirin is not stopped prior to surgery. Clopidogrel and antipla‐
telet combinations are modified based on an assessment of risk [13]. Typically, we ask pa‐
A Holistic Approach to Vascular Access in Hemodialysis
http://dx.doi.org/10.5772/53146
535
tients to omit clopidogrel for five days prior to surgery. Warfarin is omitted typically four
days before surgery to achieve an International Normalised Ratio (INR) of 1.5 or less, al‐
though there is no definitive evidence for this practice [14]. Regarding the provision of re‐
gional anaesthesia for access surgery, an INR of 1.3 or less is required. If warfarin cannot be
stopped for an interval of several days (e.g. in patients with prosthetic heart valves), then we
typically admit patients for intravenous heparin infusion that is stopped approximately two
hours prior to theatre and recommenced two hours following surgery. The platelet count
should be 50,000.μl-1 or greater but guidance on the possible qualitative defects in platelet
function due to uraemia in stage 5 CKD is not well defined [15-16].
AVF formation should ideally be timed so that patients who are deemed likely to need
access have a mature fistula when dialysis is required. Clearly, access surgery should be
performed as soon as is possible. However, this should not preclude optimisation of pa‐
tients in terms of co-morbidities and the investigation and treatment of arterial or venous
disease that  will  improve the likelihood of  a  successful  outcome.  Hastily  performed ac‐
cess  surgery in a  sub-optimised patient  is  more likely result  in the loss  of  a  potentially
precious AVF. Of course, it is possible that a patient will require dialysis during the peri‐
od of investigation, interventions or fistula maturation and a vascular catheter with their
inherent risks becomes vital.
2.1.2. Autogenous arterio-venous fistula and details of procedure
This is the gold standard and should be considered in all patients who required vascular ac‐
cess [17]. It is recommended to create a fistula in the non-dominant upper limb before ap‐
proaching other sites, particularly for those considering home dialysis. The lower limb
should be considered only when the upper limb options are exhausted given the higher risk
of infection [18]. The commonest type of autogenic AVF is radio-cephalic where the cephalic
vein is anastomosed to the radial artery at the wrist. Although initially described as a side-
to-side anastomosis, many surgeons perform end-to-side procedures, ligating the vein and
attaching the proximal vein to an arteriotomy.
Typically, in our practice, a patient will give signed consent and have the limb marked on
the day of surgery. The vein, artery and line of incision are marked approximately in par‐
allel,  with the incision mark placed closer to the artery than vein. The procedure is per‐
formed  in  theatre  under  aseptic  conditions;  venous  cannulation  is  performed  on  the
dorsum the non-surgical hand and a single bolus of a broad-spectrum antibiotic is admin‐
istered,  e.g.  co-amoxiclav 1.2g.  Unfractionated heparin is  also given via the cannula just
prior to application of arterial clamps. Monitoring of pulse and oxygen saturation is con‐
tinuous. No sedation is used.
The limb is placed on an arm board and prepared with a topical antiseptic e.g. iodine-based.
We place the unprepared hand in a clear aseptic plastic bag. Local anaesthetic, typically in
the form of 1% lidocaine, is infiltrated into the marked area. The vein is identified first, as its
status will influence the rest of the procedure. Once sufficient length is judged to be exposed
and dissected free of surrounding tissues, the vein is marked along its length with a surgical
marker pen to avoid rotation. The vein is then ligated and cut. The proximal end is initially
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flushed to check run-off, then gently occluded to assess calibre as venospasm is routinely
encountered during local anaesthesia.
Once the vein is assessed as viable, the artery is then exposed sufficiently to allow an arterio‐
tomy and placement of two paediatric non-crushing arterial clamps. The vein is cut to adjust
for length and end circumference to avoid excessive tension and anastomotic disparity.
Once clamped, an arteriotomy is made, typically of four to six millimetres and the end-to-
side anastomosis performed using a double ended 6-0 or 7-0 polypropylene suture (Figure
1). We routinely flush all vessels just prior to completion of the anastomosis to flush out any
clot that may have formed. Closure is then performed in layers with absorbable sutures. Oc‐
casionally, non-absorbable sutures are used to close the skin when the cutaneous tissue is
thin and unsuited to subcuticular closure.
Figure 1. Completion of anastomosis in a radio-cephalic fistula.
The degree of urgency and co-morbidities are factors to consider when deciding on the loca‐
tion of an AVF [19]. For patients vulnerable to factors such as reduced arterial inflow due to
cardiac failure, a proximal AVF may be preferable as it is more likely to develop quickly and
be resilient to changes in the patient’s cardiovascular status. Although more proximal AVF
are likely to achieve better primary outcomes, we strive to perform distal procedures - fre‐
quently performing snuff-box AVF, distal to the wrist in the anatomical snuff box [20]. Dis‐
tal AVF surgery can be more technically demanding because the vessels are of smaller
calibre requiring finer sutures and instruments. Despite this, the great advantage of a distal
AVF apart from ease of use for the patient and staff, is that failure will most commonly only
cause local venous thrombosis and not limit venous return for any subsequent, more proxi‐
mal AVFs. This approach allows for better utilisation of veins with potential for a greater
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number of AVF in each limb. Thus, if a snuff-box or wrist AVF fails, then a more proximal
radiocephalic or antecubital fossa AVF can be created.
An antecubital fossa AVF involves anastomosing the median cephalic vein (or local varia‐
tion of this), to the brachial artery. Other approaches include distal ulnar-basilic, radio-basil‐
ic or brachio-basilic transposition, performed as a single or two separate procedures. The
basilic transposition involves a basilic or median cubital vein anastomosis to the brachial ar‐
tery, but requires transposition of the vein from its normal deep lying medial location to an
anterior and superficial position to enable access for puncture. If the upper limbs are not
suitable or fistula maturation has failed, then the lower limbs can be used. For example, a
long saphenous vein proximal thigh loop or mid/distal superficial femoral or popliteal ar‐
tery anastomosis. Other more unusual approaches to AVF formation have been described
for patients with particular challenges for access surgeons [21].
Autogenous AVFs exhibit a long-term patency rate superior to prosthetic grafts and vascu‐
lar catheters [22]. Their relative cost is reduced with thrombosis and septic complications
tending to be low. However, there are also disadvantages including the prior requirement of
healthy veins that have not experienced inflammation and trauma leading to fibrosis and
stenoses, the commonest cause of which is repeated cannulation [23]. This is particularly rel‐
evant to the cephalic vein in the forearm, the most precious of veins for AVF formation. Vein
cannulation is a common occurrence and the importance of the cephalic vein is often forgot‐
ten by clinicians in the patient approaching end-stage kidney disease. Another important
drawback when comparing AVF to grafts is a maturation time of typically four to six weeks.
Grafts can be used far more quickly.
2.1.3. Prosthetic graft fistula
Prosthetic grafts are derived from several materials including polytetrafluoroethylene
(ePTFE) and polyurethane. Despite their relative lack of vascular compliance, ePTFE grafts
have an inherent stability as their hydrophobic properties make them less likely for blood to
adhere [24]. Perforations created by dialysis needles tend not to close but are instead occlud‐
ed by the development of a pseudointimal lining and platelet deposition. This is opposed to
polyurethane grafts, which do possess self-sealing properties. Biological grafts of bovine ori‐
gin (mesenteric vein, ureter and carotid artery) are available, but seldom used in the UK. Al‐
though more expensive than prosthetic grafts, biological grafts are less prone to infection.
Our unit uses grafts only occasionally when upper limb veins are not viable. We have a
small stock of ePTFE grafts readily available usually as standard wall six millimetre diame‐
ter, with external reenforcement for loop grafts to prevent kinking. Unlike AVF, grafts re‐
quire subcutaneous tunnelling. The most common procedures employing grafts are the
forearm loop graft with anastamoses to the brachial artery and basilic/cephalic veins and
brachio-basilic bridge graft with a venous anastamosis placed proximally towards the axilla.
Grafts, in common with AVF, require good inflow and outflow. Their advantage over AVF
is that needling can be performed much earlier (e.g. within two weeks) and cosmetically,
they may be more acceptable to patients. Where urgent dialysis is required, synthetic grafts
are available that can be used within 24 or 48 hours. Grafts can also be used for more unusu‐
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al bridge procedures, such as the necklace axillo-axillary graft and bridge grafts extending
from more central vessels in the upper and lower limbs.
2.1.4. Post-procedure follow-up
In our practice, we routinely cover wound dressings with an additional layer of soft band‐
age typically from the hand to mid-forearm. This acts as a deterrent to hospital staff inadver‐
tently grasping the surgical site in the immediate post-operative period. Following return to
the ward, the patient is typically observed for two hours to monitor for bleeding and any
acute neurovascular compromise that requires urgent revision surgery (see below). An audi‐
ble bruit and often a mild thrill should be detectable following successful surgery. The vein
in an autogenous AVF should become more prominent as maturation occurs. The patient
should be educated about managing the surgical wound and reminded about the avoidance
of cannulation and blood pressure recording in the fistula limb. In the early post-operative
period, it is imperative that maturation is assessed on a weekly basis – usually by the sur‐
geon or the vascular access specialist nurse.
During  maturation  the  vein  proximal  to  the  anastomosis  dilates  rapidly  over  a  three-
week period and then at a slower rate subsequently.  Although during this period, fore‐
arm  exercises  are  advocated  by  the  Kidney  Foundation  Disease  Outcomes  Quality
Initiative, the evidence so far for this is patchy with little randomized-controlled trial da‐
ta.  Our unit  recently conducted a pilot randomized-controlled trial  of the effects of pro‐
gressive handgrip training on autogenous AVFs.  There was a small  but sustained effect
upon the change of venous diameter and accelerated arterial remodelling in the exercise
group in the first four weeks of study [25]. These findings, although taken from a small
sample size, suggest larger studies should be undertaken to clarify the significance of this
intervention [26].  ePTFE grafts  on the contrary do not  change in size.  Another,  not  un‐
common cause of poor maturation in our population is vein branching causing flow re‐
duction in the main draining vein. This may be related to stenoses secondary to cannula
trauma.  Prompt  ligation  of  branches  usually  remedies  this,  occasionally  combined with
surgical or percutaneous management of associated stenoses.
Significant flow changes occur at the fistula anastomosis with normal laminar arterial blood
flow becoming turbulent as blood flows abruptly from a high pressure/low volume vessel
into a low pressure/high volume system with changes in wall sheer stresses. This is associat‐
ed with variable degrees of intimal hyperplasia and venous stenosis. Vein ischaemia follow‐
ing sometimes extensive dissection, is also likely to influence wall fibrosis and stenosis. Our
experience also suggests that the presence of vein valves in close proximity to the anastamo‐
sis is also associated with hyperplasia. Timely intervention using percutaneous angioplasty
or surgical revision to improve vessel calibre can preserve fistula development [27]. Grafts
can be affected by neointimal hyperplasia causing a gradual narrowing, particularly at the
venous anastomosis and can lead to significant pre-and post-stenotic stasis and thrombosis.
Flow monitoring has been advocated to detect these changes earlier, but the evidence is
mixed and good trial data is desperately needed.
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2.1.5. Long-term complications
The greatest risk universal to all fistulae and grafts is thrombosis. This may occur as an early
or late complication. Interventions for complete occlusion of AVF are very time dependent,
as unless it is immediate (typically within 24 hours of the event), the resulting phlebitis in‐
duces thrombosis and precludes a successful outcome [28]. Grafts are not subject to inflam‐
mation, although the adjacent vein will be susceptible. Thrombosed grafts can undergo
thrombectomy or thrombolysis several days following occlusion.
There is limited evidence for use of antiplatetlet agents or warfarin to maintain fistula paten‐
cy [29,30]. Further, any benefits may be offset by an increased risk of bleeding episodes. Fish
oil has also been tried, but large trials are still awaited [31]. Nonetheless, in our experience,
such measures should be considered in patients who have required multiple fistulae or
when further attempts at any form of vascular access will be extremely challenging. In our
unit, reducing flow rates are initially imaged using duplex scanning. The management of
vein or anastomotic stenoses is influenced by whether the patient is dialysis dependent. Our
preference is for surgical correction, most commonly more proximal re-implantation, over
fistulogram and fistuloplasty in patients not requiring dialysis because of the nephrotoxic
profile of the majority of contrast agents. Anecdotally and possibly related to a more elderly
population, we are encountering more ‘blow-outs’ of autogenous veins, occasionally caus‐
ing large haematoma formation and subsequent stenosis. Thinner, more fragile veins may
be a contributing factor.
Infection is a dreaded complication, particularly when using grafts and is associated with
false aneurysm formation. Local signs of inflammation such as warmth, erythema, oedema
and tenderness should raise a high index of suspicion. Cultures should be taken to target
antimicrobial therapy, although Staphylococcal-targeted antimicrobials are commonly used.
Excision of the entire graft with arterial repair is not uncommon. Infection is not exclusive to
grafts: following the advent of the buttonhole needling technique for autogenous AVFs
there have been outbreaks of infection leading to staphylococcus aureus septicaemia [32]. Au‐
togenous vein infection should be treated with conventional antibiotics and if possible alter‐
native dialysis access sought on a temporary basis. Patient and staff education is an essential
part of management and involves meticulous and repeated assessment of correct needling
technique without the introduction of healing scabs into circulation.
Neurovascular compromise to a limb following access surgery may present as the steal syn‐
drome and is characterised by classic signs of acute or worsening chronic ischaemia [33]. It
can present hyperacutely with complete anaesthesiae of the hand, pain, loss of motor func‐
tion or culminate in a more chronic form as severe ulceration and gangrene (Grade IV steal
syndrome). Acutely, this represents a surgical emergency and necessitates immediate man‐
agement to improve perfusion including revision surgery such as the distal revascularisa‐
tion and interval ligation (Dril) procedure or reversal of the fistula to prevent permanent
injury [34].
After a long period of AVF maturation, high output cardiac failure can occasionally devel‐
op. Given the burden of cardiovascular disease in the dialysis population this should not be
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forgotten as a potential cause of worsening congestive cardiac failure. This develops due to
left to right shunting of large volumes of blood via the fistula. The resulting increase in pre‐
load leads to higher cardiac output, and over time, the rise in overall cardiac workload leads
to a progressive cardiomyopathy [35]. Access flow monitoring can demonstrate massive
blood flows over the fistula (e.g. 2 litres.min-1) and echocardiography reveals variable ejec‐
tion fractions. Treatment with conventional therapies (e.g. angiotensin blockage, beta-antag‐
onists, diuretics and fluid restriction) can improve the condition, but often banding or
ligation of the AVF is needed which may create a dilemma over future vascular access.
Cosmetically, fistulae can be unappealing to some given the possible progression to aneur‐
ysmal dilation and venous collaterals from venous hypertension. The latter can be exacer‐
bated by central vein stenosis from multiple catheter usage. Central vein angioplasty with
possible stenting may be attempted to settle this but such intervention should be avoided if
dialysis is adequate. Advances in buttonhole needling techniques have seen a reduction in
the frequency of aneurysmal dilation. [36]. Occasionally, aneurysms and pseudoaneurysms
(in grafts) need to be surgically removed as they carry a high risk of bleeding and infection.
2.2. Vascular catheters
2.2.1. Requirements
Similar to AVF creation, anatomical planning is crucial to ensure a successful outcome and
reduction in complications. Deciding upon the site of catheter insertion depends upon sev‐
eral factors. Generally, haemodialysis catheters are inserted into either one of the internal
jugular veins. Commonly the right side is approached given: 1) larger lumen than its coun‐
terpart and 2) its direct path into the superior vena cava and right atrium. The course of the
left internal jugular vein is less straightforward as it makes a turn at the junction with the
left brachiocephalic vein and a second turn at the superior vena cava. If a left-sided ap‐
proach is being contemplated, it is recommended to perform this under fluoroscopic guid‐
ance so any tortuosity is safely traversed.
Although anatomical landmarks continue be used to guide insertion, current NICE guid‐
ance in the UK recommends the use of ultrasound scanning (USS) pre- and/or intra-proce‐
dure [37]. This enables the operator to accurately determine site of entry, trajectory,
proximity of the artery relative to the vein and assess vessel calibre. Compressibility of the
vein is a defining feature distinguishing it from the neighbouring artery (usually in a slight‐
ly posterior-medial position with an internal jugular approach; Figure 2). This may however
be reduced if thrombus is present. Arterial pulsation detected on USS can also act as a dis‐
criminating feature, but caution is advised in the face of a critically ill patient who is hypo‐
tensive. From our personal experience, an entry point of approximately two centimetres
above the clavicle is satisfactory. A higher approach may be less comfortable as the external
portion of the catheter may protrude into the neck and restrict movement. Moreover, a low‐
er approach facilitates conversion of a VC to a TCVC if desired at a later stage.
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Figure 2. Transverse ultrasound image of internal jugular vein with the common carotid artery in a posterio-medial
position.
Occasionally, alternative sites are sometimes sought, as patients may not be able to lie supine
for a prolonged period due to dyspnoea or cervical osteoarthritis. In addition, it is common for
dialysis patients to have multiple catheters inserted during their lifetime and this can result in
thrombosis and stenosis making future insertions difficult: attenuated internal jugular veins
with multiple collaterals is suggestive of a central occlusion [11]. Therefore, subclavian and
femoral veins can also be considered. However, the latter is thought to be undesirable given the
increased risk of infection despite evidence for the contrary [38]. Subclavian insertions are not
recommended given their propensity to subsequent stenosis or thrombosis by inducing endo‐
thelial damage and may compromise future AVF formation. Thus, the remaining discussion
will focus on the internal jugular approach as it is the most widely used.
Written informed consent is advisable. The entire procedure should be explained in detail
and complications outlined. In the emergency setting, where the patient lacks capacity to
give consent, this may not be required and the procedure can be performed under the auspi‐
ces of Common Law in the UK. Common complications include arterial puncture, bleeding
and risk of infection. In our experience, pneumothorax is overstated and is rarely seen in in‐
ternal jugular insertions. However, in a subclavian approach, there is a higher risk of pneu‐
mothorax and pleural injury given proximity of the lung apex.
Those with active septicaemia should not have a TCVC inserted where possible, but should
be postponed until negative blood cultures are obtained. Patients should also have a satis‐
factory coagulation system and similar precautions should be taken as outlined in the previ‐
ous section.
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2.2.2. Details of insertion procedure
For any insertion, an aseptic technique is essential and can be achieved readily in a pre-des‐
ignated area for catheter placement (Figure 3). Ideally, an assistant should be present who
can provide material to the operator and reassure the patient. The operator should don ster‐
ile mask, gown, gloves and a lead-protective apron if fluoroscopy is being utilised. More‐
over, a sterile drape should be placed over the patient with a window exposed over the
proposed site of catheter entry (Figure 4). Electrocardiogram monitoring can be useful to de‐
tect any ventricular arrhythmias encountered during the procedure.
The patient should be placed in the supine position with the neck turned opposite the site of
entry. If possible, the chin should also be slightly elevated. We have found that elderly pa‐
tients find this particularly uncomfortable. Pillows placed under the head and tilting the
head-end of the bed to a Trendelenberg position may resolve such difficulties (vertical head
tilt of -15 or -30°). The latter manoeuvre assists in venous filling and thus aids in identifica‐
tion and venepuncture. Otherwise, an alternative entry site should be sought.
Figure 3. The operator needs to ensure asepsis at all times throughout the procedure.
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Figure 4. Fenestrated drapes are readily available that can be placed over the procedure site. Care must be taken to
minimise patient discomfort, as this will inevitably cover their face.
Once landmarks have been identified and the exposed areas have been cleaned (iodine or
chlorhexidine 2%), adequate anaesthesia should be applied with 1% lidocaine through a 25-
gauge needle or equivalent. This should be applied generously - initially with a skin wheal
or bleb at the entry point and then subcutaneously with USS guidance down to the superior
wall of the vein (Figure 5). Visual guidance and intermittent negative suction will reduce the
risk of inadvertent intravenous or intraarterial injection. However, if this does occur, the
needle should be gently withdrawn until blood is no longer aspirated. From our experience,
this is a satisfactory approach and sedation is rarely required. Maintaining visual contact
and reassurance during the procedure can avoid the need for sedatives. However, if high
levels of anxiety are anticipated, pre-medication with a short-acting benzodiazepine may
suffice.
Following this step, a wider-bore 21-gauge needle is attached to a small syringe (five or ten
millilitres). The needle should be wide enough to accept a straightened J-curve microwire
through its lumen. Ideally, the USS image should incorporate a transverse view with the in‐
ternal jugular vein centred. The operator should limit the amount of pressure applied on the
skin as too much may obliterate a satisfactory image and result in transection of the vein.
Aiming for a similar trajectory as during anaesthetic infiltration, the needle is inserted
through the skin adjacent to the centre of the USS probe whilst applying negative suction.
Entry into the vessel is indicated by free aspiration of blood (Figure 6).
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Figure 5. The operator should use real-time USS guidance for both anaesthetic infiltration and cannulation of the in‐
ternal jugular vein. The needle in both cases should be placed adjacent to the probe.
Figure 6. Entry into the internal jugular vein will be indicated by free aspiration of blood. If blood fills the syringe in a
pulsatile fashion then arterial puncture should be suspected.
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Some authorities advocate visualisation of the needle tip in the lumen of the vessel. Howev‐
er this is not always possible, and in our collective opinion aspiration of blood is a more re‐
assuring sign of vessel entry. Carotid artery puncture will result in pulsatile filling of the
syringe and the access attempt should be abandoned temporarily and gentle pressure ap‐
plied over the puncture site for five to ten minutes. A resulting haematoma may compress
the vein and reduce visibility.
When aspiration is achieved, the operator should carefully keep the needle in position
whilst removing the syringe from the bevel. At this point, the microwire should be intro‐
duced through the bevel and passed through freely to enter the vessel (Figure 7). Occasion‐
ally, the guidewire may enter into the right ventricle and irritation may result in short bursts
of ventricular tachycardia. Simply withdrawing the wire slowly into the right atrium can re‐
solve this. If resistance is encountered then gently withdrawing around one centimetre and
twisting the guidewire before reintroducing may help, as the wire may be deflected superi‐
orly within the vein. Otherwise, the syringe should be reapplied and checked to see if blood
is freely aspirating. If not, the needle should be completely withdrawn and puncture reat‐
tempted. The wire should not be pulled through the needle, as there is a theoretical risk that
the sharp bevelled needle can sheer off the tip of the microwire – particularly if a kink had
developed [39]. Kinked wires may restrict passage of the catheter and should therefore be
replaced with a fresh wire. If despite clearly entering the vessel and obtaining good aspira‐
tion flow, guidewire passage fails, then possibilities include stenosis or a collapsing vessel.
Such circumstances may be remedied by asking the patient to perform a Valsalva manoeu‐
vre to aid venous filling or using a thinner guidewire coupled with real-time fluoroscopic
screening [40].
Figure 7. The microwire usually has to be straightened at the J-tip to permit smooth entry through the wide-bore
needle.
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Figure 8. Once in place the needle should be removed over the wire whilst ensuring the wire is stabilised.
If a guidewire has been successfully introduced, the wide-bore needle should be removed
over the wire (Figure 8). At this point, fluoroscopy should be used to image the path of the
wire, which should lie in the right atrium. A 0.5-1 centimetre horizontal incision is made
over the superior end of the wire’s exit point and widened with mosquito forceps (Figure 9).
Care should be taken that there are no skin tags and the wire freely moves across the inci‐
sion. A smaller incision can lead to considerable resistance when introducing dilators or a
catheter and may result in the guidewire kinking.
Figure 9. The scalpel blade should be inserted over the superior aspect of the guidewire.
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Figure 10. A stiff flexible dilator is placed over the wire to puncture the vein and form a tunnel that will permit
smooth passage of the catheter. Knowing how far the dilator needs to be pushed in can be estimated from the dis‐
tance of the internal jugular vein to the skin using ultrasound.
A stiff  dilator  is  then inserted over the guidewire (Figure 10).  There are two aspects  to
take note at this point: firstly, it is advisable to forewarn the conscious patient that dilator
insertion will cause pressure discomfort; secondly, the dilator should be inserted in a firm
but smooth motion from the distal (tip) end so as to avoid guidewire kink. Advancing the
dilator  several  centimetres  is  only  required:  pushing  further  may  theoretically  result  in
vessel  damage –  particularly  in  a  left  internal  jugular  approach owing to  its  tortuosity.
Following removal of the dilator heavy bleeding may occur, so pressure over the exit site
must be applied.
The  catheter  should  then  be  placed  over  the  guidewire  until  its  tip  is  seen  protruding
from one of the catheter hubs. The remaining length of catheter can then be inserted to
its  hilt  with simultaneous withdrawal of  the wire (Figure 11).  Free aspiration should be
attempted from each hub to ensure smooth flow in and out. If there is resistance, it may
indicate that suction of the distal tip against the atrial wall. The catheter should be flush‐
ed with saline through each port and a heparin lock solution applied. This may take the
form of 5000 iu of heparin diluted 1:5 or a preformed solution with anticoagulant and an‐
timicrobial properties (e.g. TaurolockTM). There is evidence that filling the hubs after dial‐
ysis  with  antibiotic  solution  prevents  the  formation  of  a  biofilm  inside  the  catheter
lumen: biofilms can form within 24 hours after placement and create an opportune envi‐
ronment for bacterial  colonisation [41].  The final stages of the procedure should include
applying sutures to the entry site and to secure the line (Figure 12). The neck should be
cleaned thoroughly and dried before applying adhesive dressing. Sutures should remain
in-situ for the duration of catheter use,  but be inspected regularly for evidence of infec‐
tion or suture abscess.
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Figure 11. Once the catheter has been fully inserted to its hilt, flow should be immediately checked and be smooth
with little effort required. Any resistance may complicate subsequent dialysis. Testing should be followed with liberal
saline flushes.
Figure 12. Two sutures should be applied at the butterfly wing as shown to anchor the catheter and avoid dis‐
placement.
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2.2.3. Tunnelled catheter insertion
Most TCVCs are derived from polyurethane or silicone. This provides good elasticity and
enough rigidity to permit high flow rates required during renal replacement therapy. Nu‐
merous designs are available but no one specific design shows significant superiority over
another [42]. It is useful to have a non-sterile TCVC to assess the length required and loca‐
tion of the intended exit site prior to the actual procedure. Clearly, owing to the tortuous
course of the left internal jugular vein, a longer catheter is usually required. Body habitus is
also another factor to consider with smaller individuals probably requiring shorter catheter
lengths. Additionally, predicting whether the tip will suck against the atrial wall after place‐
ment is important as this can influence flow rates.
Essentially, most of the above applies to insertion of TCVCs, though several additional steps
during the procedure should be noted. Firstly, once the guidewire has been inserted into the
internal jugular vein, the horizontal incision made superior to the wire should be followed
by generous widening with a mosquito forceps - prising apart subcutaneous tissue bridges
(Figure 13). This is thought to reduce the risk of intractable kinking at the turning point of
the catheter.
Secondly, a subcutaneous tunnel has to be created for the entry point for this is usually on
the chest wall, and this is best achieved by using a lumbar puncture needle to inject anaes‐
thetic up to the entry point of the internal jugular vein. The catheter is then tunnelled
through with gentle pressure using a pliable metal introducer (attached to the catheter tip)
out through the entry point incision, adjacent to the guidewire. The tunneller is then discon‐
nected from the catheter. Sometimes, it is preferable to perform a two-stage tunnelling proc‐
ess to form a smooth curved entry into the internal jugular vein, which may reduce chances
of kink formation and thus sluggish flow. If a kink is encountered following the procedure,
occasionally a gentle pull of the catheter from the proximal (hub) end may resolve this. Once
tunnelled, the polyester (Dacron) cuff should lie subcutaneously within the formed tract.
Over time, a fibrotic reaction between the cuff and the subcutaneous tissue occurs and thus
provides effective stabilisation and a mechanical barrier to infection. If a cuff does not ad‐
here sufficiently, the catheter may become displaced and “fall out”. In such cases, no at‐
tempt should be made to reintroduce any exposed catheter back into the tract but it should
be removed and replaced when convenient.
Finally, TCVC kits usually include several dilators of differing diameter. All should be used
to create a satisfactory puncture within internal jugular vein to facilitate insertion. Of note,
the catheter tip is inserted into the vein by means of a “pull-apart” introducer/dilator. This is
inserted last in a similar fashion to a dilator device, but has a central lumen capable of ac‐
commodating the dialysis catheter through into the vein once its central stiff portion has
been removed. Sutures (2-0 Prolene) should be applied to the entry point to the internal jug‐
ular and proximally at the butterfly wing. The latter sutures can be typically removed after
ten days.
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Figure 13. Successful insertion of guidewire into right internal jugular vein. Tunnelled catheter can be seen adjacent,
ready for final placement.
Figure 14. Post-procedure chest radiograph with the tip of the tunnelled catheter within the right atrium.
2.2.4. Post-procedure
A post-procedure chest radiograph is essential to assess the position of the catheter tip and
check for any complications (e.g. pneumothorax or inadvertent insertion into azygous vein).
Position of the catheter tip is a point of contention: most operators believe the ideal location
is the junction of the superior vena cava and right atrium (Figure 14). If the tip is lower it
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may induce ectopic beats and possibly occlude if it is opposed against the vessel / atrial wall.
If the tip is not in satisfactory position, gentle catheter withdrawal and re-imaging may be
attempted. Pneumothorax should be treated by conventional means.
2.2.5. Complications
Bleeding is common early complication that usually responds to firm compression over the
exit site for up to 30 minutes. This can be followed by application of a pressure dressing
and/or haemostatic wound dressing [43]. If these measures fail, then a purse-string suture
can be performed. This should be left for a period of no more than 24 hours. However, in the
rare event of persistent bleeding, thrombin can be injected into the tunnel or the catheter
should be removed altogether [44]. Additionally, if there has been considerable bleeding
during the procedure it is common practice to administer a single dose of vancomycin (1g
IV) post-procedure to reduce the possibility of bacteraemia. Although this is widely prac‐
tised, the evidence-base for this is currently lacking [45].
After each dialysis session, both hubs should be locked with an anticoagulant and/or antimi‐
crobial solution. Various types are available and there is some evidence that citrate-based
solution may offer distinct advantages to heparin [46]. If poor access flow occurs, then trial
with an infusion of a thrombotic agent (e.g. tissue plasminogen activator 1mg.ml-1 or uroki‐
nase 5000 IU.ml-1) may be helpful in removing thrombosis within the lumens. Recurrent
blockages may respond to low dose warfarin to maintain patency (aiming for an INR of 1.4 –
1.9), but again the evidence for this is very limited at best [47]. Occasionally, poor flow may
also result from catheter kink and repositioning the patient during dialysis can be tried.
When all these measures fail, catheter removal and replacement is indicated.
Infection is a widely recognised problem with indwelling dialysis catheters – especially
long-term tunnelled lines. The prosthetic nature of the catheter promotes formation of bio‐
films within the lumen and can result in exit site infections or bacteraemia [40]. Staphyloccoc‐
ci, corynebacterium and enterobacter are common culprits and dialysis units should have
protocols in place to treat such infections. In our unit, exit site infection is swabbed for mi‐
croscopy, culture and sensitivity. If fever is present, peripheral and catheter blood cultures
must be taken. Methicillin-resistant staphylococcus aureus (MRSA) remains a serious problem
in UK dialysis unit [48]. Pending results, appropriate empirical staphylococcal antibiotic in
the form of vancomycin should be administered as this will cover MRSA and methicillin-
sensitive (MSSA) strains. If MRSA is confirmed then intravenous vancomycin should be
continued for a minimum of two weeks for exit site infections. Gram-negative cover can also
be considered, but this depends upon local microbiological epidemiology. Given that vanco‐
mycin is renally excreted, dosing schedules should be based on trough levels every four to
seven days, aiming for a therapeutic concentration between 10 to 15 mg.l-1. For MSSA, an
oral course of flucloxacillin should suffice for a local exit site infection.
If infection is more severe (e.g. the presence bacteraemia, systemic features of illness or tun‐
nel track infection), lengthy intravenous treatment is recommended. Patients should also be
thoroughly examined and appropriately investigated for evidence of bacterial seeding e.g.
endocarditis and septic arthritis. Management of other organisms should be discussed with
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microbiology services. If despite these measures there is a lack of response and the catheter
cannot be salvaged, the removal is the most effective form of treatment [49]. Nonetheless,
this often is a last resort option, especially in patients whom achieving any form of vascular
access is historically very difficult. There is no benefit in attempting to salvage temporary
devices and these should be removed and replaced if required.
Following insertion of all catheter devices, patient education is of paramount importance to
ensure longevity and to reduce infection. Keeping the catheter dry is important and ensur‐
ing aseptic technique whenever handled – particularly in patients who perform home dialy‐
sis. There is limited evidence that staphylococcal screening and decolonisation may reduce
the incidence of catheter-associated infection, but large trials are lacking to assess the cost-
effectiveness of this approach [50]. In general, in-house quality assurance programs should
be implemented to ensure best clinical practice with lowest infection rates possible and will
require a multidisciplinary approach.
2.3. The role of the vascular access nurse
In 2004, the Department of Health in England and Wales launched The National Service
Framework for Renal Services. In this document one of recommendations as a marker of
good practice is that all patients with established renal failure receive ‘timely preparation for
renal replacement therapy’ as well as ‘timely and appropriate surgery’ for permanent vascular ac‐
cess which is ‘monitored and maintained to achieve it maximum longevity’ [51]. Later, when re‐
viewing the provision of vascular access services and the volume of the workload, a joint
report with the Renal Association UK recommended that units providing vascular access for
patients appoint a dedicated vascular access co-ordinator to ensure smooth progression
throughout the patient pathway [52]. Today, an extensive network of vascular access nurse
specialists exist working within UK renal units to improve service delivery with an particu‐
lar emphasis on minimizing the use of dialysis catheters.
2.3.1. Identification of patients
One of the broad roles of the vascular access nurse is to work closely with other members of
the renal team to identify the most suitable type of renal replacement therapy for patients,
whilst taking into account the patient’s wishes and preferences. Current best practice is that
65% of patients starting HD do so with a fully functioning AVF and that planning should
take place when the patient has reached CKD Stage 4 or an eGFR of 30 ml.min.1.73m2-1 or
less [53,54]. Through liaising closely with the patient, family and renal team during the early
stages of planning allows one to identify potential problems that may contribute to creating
access and permit timely, appropriate referral to the surgical and radiological teams. It is
suggested that vascular access is created six months prior to the anticipated start of HD or
even earlier [55-57]. This period accounts for planning, creation and maturation of the access
and any further procedures that may be necessary to ensure functionality [58]. Overall, this
strategy enables the delivery of an individualized plan of care.
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2.3.2. Information provision
The vascular access nurse can be a valuable source of information and advice. The importance
of preserving veins for dialysis access cannot be emphasized enough (Figure 15). As discussed
above, patients with CKD undergo frequent blood sampling that damages veins rendering
them unsuitable for access creation, and a plan to preserve vessels should be made early on
[59,60]. Moreover, following fistula creation, patients and caregivers should be constantly re‐
minded of vascular preservation for future access and inappropriate use of a fistula (Figure 16).
Figure 15. Custom armbands can help warn patients and healthcare staff about vascular preservation for access crea‐
tion and therefore avoiding venepuncture.
Figure 16. Sadly, this is still a common site where even after fistula creation, vascular access for dialysis is abused. Edu‐
cation of staff is of paramount importance to prevent this potentially catastrophic occurrence.
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Patients with CKD often attend multiple hospital clinics and careful planning of appoint‐
ments by the vascular access nurse to coincide with each other may reduce the number of
visits to hospital. One-stop access clinics, whereby the patient is reviewed by the vascular
nurse and surgeon, receives Doppler scans of both arms as well an pre-operative assess‐
ment, have been shown to greatly reduce the number of hospital appointments [61]. Follow‐
ing AVF creation, studies indicate that there is developmental change from two to four
weeks, and that skilled physical assessment can accurately predict its maturity for cannula‐
tion [62]. Early follow-up and assessment of the patient by the access nurse is critical to en‐
sure that prompt action and re-referral to the surgeon can be taken should the fistula fail for
the initiation of dialysis.
2.3.3. Assessment pre- and post-access creation
By becoming familiar with the patient in the early stages of assessment enables the access
nurse to manage the referral process efficiently and to prioritise the surgical waiting list ac‐
cording to the rate of decline in eGFR and patient symptoms. This helps expedite surgery,
investigations and revisions according to clinical need, as well as providing a ‘familiar face’
and a point of contact for the patient.
2.3.4. Access monitoring
Another essential but labour-intensive role of the access nurse is monitoring, surveillance
and co-ordination access salvaging procedures within the entire HD population. The use of
advanced surveillance techniques are recommended by the Renal Association in addition to
systematic observation of access [53]. Although it is accepted that monitoring and surveil‐
lance of vascular access is an integral part of HD patient care, evidence in the form of
randomized controlled studies is lacking as to the most effective method of access surveil‐
lance [59]. Nonetheless, it is accepted that measuring access flow is an accurate predictor of
AVF or graft dysfunction and all surveillance methods are directly or indirectly linked to
this [53,57]. Many units now use flow-based methods of measuring access flow (QA) and re‐
circulation (such as the TransonicTM ultrasound flow dilution system), that has the advant‐
age of being performed during HD and thus limits patient inconvenience. Access flows of <
400 ml.min-1 or < 600 ml.min-1 in grafts can indicate stenosis and therefore a high risk of
thrombosis. This also can limit blood pump flows (QB) and lead to recirculation – both im‐
pacting upon kT/v.
It is important note that access flow readings only represent one aspect of monitoring and
that a compete clinical picture is established in conjunction with other information, includ‐
ing: physical examination of the fistula, the presence of cannulation problems, dialysis clear‐
ance and the patient’s general physical condition. Further investigation is often necessary -
initially in the form of USS and then contrast-based fistulograms to establish the presence of
a lesion affecting the flow (e.g. stenosis or aberrant tributaries). Indeed, the access nurse has
a pivotal role in coordinating these investigations and arranging interventional radiology or
surgery if necessary [61].
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The success of monitoring and surveillance depends on a team approach with good com‐
munication between all members of the renal team and the dialysis nurses who manipu‐
late  access  on  a  daily  basis  [59].  Depending  on  patient  numbers  and  workload  of
individual units, the access nurse can be directly responsible or can coordinate with desig‐
nated dialysis “link” nurses to conduct surveillance. Finally, the patient should be encour‐
aged to familiarize themselves with their vascular access and alert staff to any unexpected
changes.
2.3.5. Education
Regular education of staff and patients on access-related issues is essential for preservation,
as poor needling techniques can cause damage to fistulas, stenosis and subsequent risk of
failure. Written protocols for cannulation of fistulas, handling central venous catheters and
physical examination of the fistula prior to cannulation should exist and be managed by the
access nurse with clinical competency assessments performed periodically to ensure stand‐
ards are maintained. The access nurse can also assist with cannulation care planning, diffi‐
cult cannulations and advising on the most suitable technique for individual patients. For
example, it is important to ensure that the fistula is not ‘area needled’, which can result
weakening of the vessel wall and subsequent aneurysm formation [63]. Although the but‐
tonhole technique is currently the favoured cannulation technique preferred by staff and pa‐
tients, the risk of infection is higher than the more traditional site rotation method [64,65].
Patients should be therefore risk profiled before using buttonholes, and if selected, educated
to minimize the risk of sepsis. Notwithstanding, the buttonhole technique does contribute to
preservation of the fistula for patients with a limited needling area and is aesthetically more
pleasing when body image is an important consideration (Figures 17 and 18). It has also pro‐
ven to be an integral part of care for our patients on daily home dialysis.
Figure 17. Buttonholes in a 78 year old female patient.
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Figure 18. Buttonhole sites after 6 months in 21 year old, needle phobic male patient. Both patients had major issues
regarding body image prior to fistula creation.
2.3.6. Vascular catheter care
While it is accepted that vascular catheters should not be actively encouraged as first-line
HD access, often the vascular access nurse plays a pivotal role in catheter care. Many of the
above principles apply to central venous catheters usage. The main issues concerning the ac‐
cess nurse involve minimizing infections and promptly treating poorly functioning catheters
- a relatively common event for HD patients [53]. Regular assessment of catheters can detect
failing flow and ensure that prompt action is taken to avoid further dysfunction or complete
failure. Similar to AVFs and grafts, protocols should be in place for catheter maintenance
and dysfunction as well as for rapid treatment of sepsis - suspected or proven. Increasingly,
there has also been development of a more “hands-on” approach encompassing catheter in‐
sertion and removal. Within the UK, this has been extended in some units to involve vascu‐
lar access nurses independently inserting catheters after undergoing a comprehensive
training programme, and has the distinct advantage of reducing waiting times and burden
on clinical staff [7,66].
2.3.7. Audit and research
Monitoring of access outcomes and documentation allows for future planning and clinical
audit. This and research are essential to evaluate outcomes and provide up-to-date, evi‐
dence-based care. In an area of dialysis care that is continually evolving, the access nurse
needs to be flexible with the role according to the ever-changing needs of the patient and the
requirements of the service.
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The target of 85% prevalent HD patients dialysing with an autogenous AVF has been a chal‐
lenge to achieve by many renal units in the UK as indicated by data collected by the national
Renal Registry [53,67]. There is now increasing evidence that appointing a vascular access
nurse reduces catheter use in favour of autogenous AVFs [68]. In our unit, AVF prevalence
has risen from 60% to 82% since appointment in 2009, and statistical analysis of our out‐
comes indicate that a regular programme of monitoring and surveillance has helped to ach‐
ieve this and improving dialysis adequacy above the Renal Association standard. This is not
only due to the increase in fistula prevalence, but an improvement in the quality and surviv‐
al of existing fistulae through emphasis on prompt referral for investigation and interven‐
tion for poorly functioning ones.
3. Concluding remarks
Vascular access in haemodialysis is crucial step to maintain quality of life once native renal
function ceases. The acute setting differs markedly from chronic disease where the patient
will encounter numerous specialties and procedures on multiple occasions. The procedures
involved are complex and require detailed planning to ensure good outcomes and reduce
short- and long-term complications. A multidisciplinary approach is commonplace and
roles within the context of vascular access are constantly evolving to optimise care. Imple‐
mentation of a vascular access nurse ensures that the patient’s journey into haemodialysis is
a timely one and follow-up care is likewise.
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